Pillstats
Rx only · Patch, Extended Release · Transdermal

Scopolamine

Brands: Transderm Scop · Scopolamine

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US11 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)9601
US makers8 labelers
Packages26
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.57$3.14$4.71$6.28Dec 2025Mar 2026Jul 2026
$5.311
Latest avg · Jul 22, 2026
+5%
Since Dec 17, 2025
8
Active US suppliers
38%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

19K38K58K77K2025 Q12025 Q22025 Q32025 Q42026 Q1
64K
Rx · 2026 Q1
486K
Units dispensed
+42%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager6SUPPLYING
Baxter Healthcare Corporationunknown4SUPPLYING
Rhodes Pharmaceuticals LLCunknown3SUPPLYING
Ingenus Pharmaceuticals, LLCunknown3SUPPLYING
Amneal Pharmaceuticals LLCunknown3SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown3SUPPLYING
Zydus Lifesciences Limitedunknown3SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 13, 2022
    RECALLRecall (Class II): Transderm Scop (scopolamine) Transdermanl System, 1 mg/ 3 days, 10 (patches) transdermal Systems Multipack, Rx only, MF…

    cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.